Ergoloid Mesylates is used in the treatment of Alzheimer's disease, stroke, dementia in Parkinson's disease, age related memory loss and head injury.

Ergoloid mesylates act centrally, decreasing vascular tone and slowing the heart rate, and acts peripherally to block alpha-receptors. One other possible mechanism is the effect of ergoloid mesylates on neuronal cell metabolism, resulting in improved oxygen uptake and cerebral metabolism, thereby normalizing depressed neurotransmitter levels.

Vomiting, Gastrointestinal disorder, Lightheadedness, Loss of appetite, Running nose, Nasal congestion, Stomach upset, Tongue ulcer, Warm sensation